Home » Stocks » RACA

Therapeutics Acquisition Corp. (RACA)

Stock Price: $14.07 USD -0.03 (-0.21%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $13.85 -0.22 (-1.56%) Jan 15, 6:17 PM
Market Cap 251.43M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 14.04M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $14.07
Previous Close $14.10
Change ($) -0.03
Change (%) -0.21%
Day's Open 14.10
Day's Range 13.82 - 14.13
Day's Volume 15,005
52-Week Range 12.02 - 15.85

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 4 months ago

These shell companies allow the businesses they acquire to go public much more quickly than an IPO would. Is it time to buy in?

Other stocks mentioned: INVA, JAZZ, TBPH, TXAC, TXG
The Motley Fool - 5 months ago

Forget traditional IPOs! This blank check vehicle is proving to be an effective tool for biotech companies to raise capital.

Other stocks mentioned: IMVT, PHGE, TXAC
Business Wire - 6 months ago

BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. (Nasdaq: TXAC) (the "Company") announced today that on July 10, 2020 it closed its initial public offering of 13,570,000 shares ...

The Motley Fool - 6 months ago

The special purpose acquisition company is sponsored by RA Capital Management.

About RACA

Therapeutics Acquisition, doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.

Industry
Shell Companies
IPO Date
Jul 8, 2020
CEO
Dr. Peter Kolchinsky Ph.D.
Stock Exchange
NASDAQ
Ticker Symbol
RACA
Full Company Profile